ABM Respiratory Care Secures $14.8M Funding for Growth
ABM Respiratory Care Successfully Closes Its Series B Financing
ABM Respiratory Care (ABMRC), a pioneering medical technology company focused on airway clearance and ventilation solutions, has successfully completed an oversubscribed Series B financing round, raising an impressive $14.8 million. This funding surpasses their initial goal of $12 million. The financing was led by Peter Soderberg, Chairman of the Board and Managing Partner of Worthy Venture Resources, LLC, who significantly increased his investment in the company. The round also saw substantial support from Blue Wave Capital, LLC, alongside both new and existing investors committed to enhancing innovation within respiratory care.
Strategic Plans for the Investment
CEO Greg Miller expressed enthusiasm about this investment, highlighting its importance in expanding access to their innovative respiratory therapy platform. He stated, "This investment is pivotal as we strive to provide transformative solutions for individuals facing breathing difficulties." He further thanked investors for their belief in the vision of interconnected therapies that enhance the lives of patients around the globe.
Growing Investor Confidence
Peter Soderberg also shared his rationale for increasing his stake in ABMRC, citing the company’s impressive track record and the successful performance of its initial devices in treating patients across various care settings. He said, "The opportunity to support ABMRC's growth is exciting, as our technology is integral to improving patient outcomes worldwide." This sentiment reflects the growing confidence in ABM Respiratory Care's direction and the significance of their technology in the healthcare sector.
Funding Utilization Focused on BiWaze® Clear
The newly acquired funds will largely support the commercialization of BiWaze® Clear, ABM Respiratory Care's latest advancement in airway clearance systems designed for use both in hospitals and at home. The allocation includes enhancing sales efforts within the U.S., expanding clinical research, and improving patient engagement along with digital health features.
Innovative Features of BiWaze® Clear
BiWaze® Clear stands out by facilitating more efficient lung clearing through the integration of three therapeutic modalities: lung expansion, high-frequency oscillations, and aerosol delivery paired with an integrated nebulizer. The device’s compact and battery-operated design, combined with its dual-lumen circuit, allows for a portable, closed-loop system that effectively targets aerosol deposition deep within the lungs. This design not only boosts mucus clearance but also minimizes therapy time, ensuring that patients can utilize it conveniently at home or in hospital environments.
About ABM Respiratory Care
Dedicated to enhancing patient care, ABM Respiratory Care focuses on creating intelligent, clinically distinct respiratory solutions that help improve breathing for individuals in and out of clinical settings. Their innovative platform aims to boost respiratory therapy effectiveness by fostering deeper breathing, optimizing oxygen exchange, and minimizing aerosol exposure. This comprehensive approach supports better disease management for those with compromised respiratory functions, regardless of their care environment.
Frequently Asked Questions
What is the purpose of the Series B funding for ABMRC?
The Series B funding will help accelerate the commercialization of BiWaze® Clear and enhance respiratory care solutions.
Who led the Series B financing round for ABM Respiratory Care?
The financing round was led by Peter Soderberg, ABMRC's Chairman of the Board and Managing Partner of Worthy Venture Resources, LLC.
What are the key features of BiWaze® Clear?
BiWaze® Clear combines lung expansion, high-frequency oscillations, and aerosol delivery in a portable device designed for effective lung clearance.
How does the device enhance patient care?
It offers a compact design that improves aerosol deposition, mucus clearance, and reduces therapy time for users.
What is the mission of ABM Respiratory Care?
ABM Respiratory Care aims to advance respiratory care by developing innovative solutions that improve breathing for patients globally.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.